U.S. medical device firms set visit to India
A U.S. trade delegation to India in early February will give U.S. companies an entrée into the $500 million medical device market in that country.Medical device exports from the U.S. to India have grown 20% annually in recent years and are on pace to
A U.S. trade delegation to India in early February will give U.S. companies an entrée into the $500 million medical device market in that country.
Medical device exports from the U.S. to India have grown 20% annually in recent years and are on pace to surpass $90 million this year, according to Matthew Edwards, a spokesperson for the U.S. Department of Commerce. Edwards attributed the growth to India's burgeoning middle class, which is increasingly turning to imported medical technology.
The trade mission, scheduled for Feb. 4 to 11, will visit New Delhi, Chennai (Madras), and Mumbai (Bombay). The program will include meetings with regulators, health officials, and purchasing organizations, as well as visits to hospitals and briefings by the U.S. Embassy.
Companies may send one representative for $3200, which includes all organized activities. A second person may attend for a reduced fee of $1000. The fee does not include hotels, meals, or travel costs. For information,
contact Edwards at the U.S. Department of Commerce, 202/482-4431.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
